Chemotherapy resistance is one of the major challenges for the treatment of osteosarcoma (OS). The potential roles of oestrogenic signals in the chemoresistance of OS cells were investigated. As compare to the parental cells, the doxorubicin and cisplatin (CDDP) resistant OS cells had greater levels of oestrogen-related receptors alpha (ERRα). Targeted inhibition of ERRα by its specific siRNAs or inverse agonist XCT-790 can restore the sensitivity of OS resistant cells to chemotherapy. This might be due to that si-ERRα can decrease the expression of P-glycoprotein (P-gp, encoded by ABCB1), one important ABC membrane transporter for drug efflux.
| INTRODUCTION
Osteosarcoma (OS) is an aggressive and common type of solid bone tumours in children and adolescence. 1 Surgical resection, chemotherapy and radiotherapy have been considered as the standard treatment strategies for OS. 2 With the improvement of therapy approach, the mortality rate of OS has a huge decline in these two decades. 3 The 5-year survival rate of OS patients is about 70%
within the past decades. 4 However, chemotherapy resistance, defined as tumour cells can develop resistance to a wide variety of anticancer drugs, is one of the most important formidable obstacles in the OS treatment.
2 Doxorubicin (Dox), cisplatin (CDDP), methotrexate and ifosfamide are the first-line chemotherapy drugs for OS patients. 5 Once the patient was resistance to these drugs, there are no established second-line chemotherapy drugs anymore. 1 Therefore, studies about the mechanisms responsible for chemoresistance of OS cells would be great important for developing effective therapies for OS patients.
The development of drug resistance is associated with multiple mechanisms. The most important mechanism responsible for cancer chemoresistance is the dysregulation of ABC membrane transporters. 6, 7 Among all members of ABC family involved in chemoresistance, P-glycoprotein (P-gp), encoded by ABCB1 (also named MDR1), is highly expressed in the drug resistant cell lines to pump Yantao Chen and Kunshui Zhang contributed equally to this work.
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out the intracellular drugs. 8 The down-regulation of ABCB1 can sensitize OS cells to chemotherapy drugs such as Dox and CDDP. [9] [10] [11] Although the transcription regulation of ABCB1 is far from being completely understood, numerous studies indicated that transcription factors such as c-jun, c-fos, NF-kB (p65) and Sp3 can bind to its promoter to regulate the transcription. 12 As to the protein, P-gp is a relatively stable protein with a half-life of 14-17 hours, while modification by ubiquitin is important for degradation of P-gp. 13 Besides, ABCC1 (also named MRP1), ABCC2 (MRP2), ABCC3 and ABCG2 (BCRP) can also contribute to drug resistance of OS cells. 14, 15 It has been reported that oestrogenic signals can regulate the progression of various cancers including chemotherapy resistance. [16] [17] [18] For example, IL-1β induced methylation of ERα is correlated with the chemoresistance in breast cancer cells. 
| Real time PCR for miRNA
RNAs were extracted by use of Trizol according to the manufacturer's protocol and reverse transcripted to cDNA by use of the One
Step PrimeScript ® miRNA cDNA Synthesis kit. The expression of miRNAs was determined by comparative CT method (RQ = 2 
| Western blot analysis
After treatment, cells were homogenized and lysed by use of cold RIPA buffer. Next, 30 μg of total protein was separated with a 4%- 
| Cell transfection
The negative control, siRNAs for ERRα and SP3, and miR-9 inhibitor and mimic were purchased from Guangzhou Ribo BioCoLTD After transfection for 6 hours, the medium was replaced by full medium containing 10% FBS.
| Dox efflux assay
Effects of ERRα on the Dox efflux were tested by use of flow cytometry according to the previous study. 27 Cells were treated with 5 μmol/L Dox for 1 hour in darkness at 37°C. After treatment, cells were washed and collected for analysis by use of a flow cytometer (BD Biosciences, San Jose, CA, USA) using an argon laser of 15 mW at 488 nm.
| Promoter activity assay
The promoter of ABCB1 (−1000 to −1 bp) was cloned to the luciferase promoter to generate pTL-MDR1. Cells were transfected with pTL-MDR1 and pBABE-puro using Lipofectamine 2000 reagent (Invitrogen) and further treated with or without XCT-790 for the indicated time periods, the luciferase activity was normalized to total proteins determined by use of BCA assay.
| Immunoprecipitation assay
The binding between ERRα and SP3 was measured by immunoprecipitation assay in OS cells. Cell lysis was incubated with IgG or ERRα antibody over night at 4°C. After further incubated with protein A agarose beads for 4 hours, the immunoprecipitate was washed for three times and subjected to western blot analysis. The antigen-antibody complexes were visualized by chemiluminescence. 
| ERRα was up-regulated in chemoresistant OS cells
Our previous study showed that ERRα participates TGF-β induced EMT of OS cells. 25 We 
| ERRα was involved in the chemoresistance of OS cells
In order to investigate whether ERRα was involved in the chemoresis- 
| ERRα regulated the expression of P-gp in OS chemoresistant cells
We further checked the effects of ERRα on the expression of various ABC membrane transporters including ABCB1, ABCC1, ABCC2, Figure 5D ). Further, dual luciferase assay showed that both XCT-790 ( Figure 5E ) and si-ERRα (Figure 5F ) can decrease the promoter activity of ABCB1. These results suggested that ERRα regulated the transcription and mRNA stability of ABCB1.
| ERRα bound to SP3 to increase the transcription of ABCB1
It has been suggested that SP3 can regulate the transcription of ABCB1 in various human tissues. 28 We then investigated SP3 was showed that in cells transfected with si-SP3, the XCT-790 suppressed transcription of ABCB1 was abolished ( Figure 6D ). ERRα has been reported to regulate the proliferation, migration and epithelial to mesenchymal transition of cancer cells. 32, 33 Recently, studies also suggested that ERRα mediates metabolic adaptations driving drug resistance in breast cancer. 23, 34 Our study that miR-9 can direct bind to the 3′UTR of ABCB1 and then trigger its decay in cancer cells. 26 As a transcription factor, ERRα might occupy the conserved ERRE in the promoter of miRNAs and then regulate their expression. 41 The mechanisms that XCT-790 induced up-regulation of miR-9 should be further investigated in the future. 
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